Atlas Trials

Neoplasms, Unknown Primary

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neoplasms, Unknown Primary

RecordFirmDate
Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP (NCT04025970)Christer Ericsson2019-09-30
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary (NCT02628379)Foundation Medicine2015-05-01
Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP (NCT01540058)Gustave Roussy, Cancer Campus, Grand Paris2012-03-22
Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP) (NCT01202786)Teva Branded Pharmaceutical Products R&D, Inc.2010-05-01
Paclitaxel/Carboplatin With or Without Cetuximab in CUP (NCT00894569)Heidelberg University2009-07-01
Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site (NCT00193609)SCRI Development Innovations, LLC2004-09-01
Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site (NCT00193622)SCRI Development Innovations, LLC2004-04-01
Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site (NCT00193596)SCRI Development Innovations, LLC2003-09-01

Track Neoplasms, Unknown Primary automatically

Every clearance here is in the API, with alerts when new ones post.